scorecardresearch
Add as a preferred source on Google
Monday, September 29, 2025
TopicPharmaceuticals

Topic: Pharmaceuticals

‘US will announce major tariffs on pharmaceutical imports,’ says Trump at NRCC event

Speaking at an event at the National Republican Congressional Committee, Trump said the tariff will incentivize drug companies to move their operations to the US.

Indian pharmas improved USFDA compliance, but cases of contamination grew 2014-2024—McKinsey report

The report, released at Global Pharmaceutical Quality Summit in Mumbai, draws comparison of incidences of ‘official action indicated' after USFDA inspections a decade apart.

India, Nigeria to discuss bilateral trade & investment at Joint Trade Committee meeting

The JTC will also discuss the resolution of market access issues faced by both countries and promote cooperation in key sectors.

Govt departments split as trade talks with European pharma firms hit last lap, patent key issue

Last month, at least two meetings were held between representatives of India & European Free Trade Association. The FTA with the 4-nation bloc is likely to be finalised this month.

Mysterious middleman may be new link in India-made cough syrups deaths in Gambia

Drugs regulator told WHO in December that the propylene glycol used in the syrups came from Goel Pharma Chem, a Delhi-based pharma-supplies company.

Once a Covid ‘wonder drug’, Remdesivir’s sales hit low in Nov, didn’t soar again with 3rd wave

Rs 6.4 cr worth of Remdesivir was sold in November, and Rs 12 cr in December, compared to Rs 287 cr in April 2021. Doctors say milder cases and better understanding is reason why.

Drugmakers cry ‘monopoly’ as Modi govt picks 1 firm each to make over 20 key raw materials

PLI scheme is supposed to end India’s dependence on Chinese imports, but drug lobby says firms could end up dependent on one company for a molecule, increasing patients’ bills.

Swiss study links higher-dosage paracetamol tablets to poisoning

Based on the findings, researchers from ETH Zurich have said people should not keep popping paracetamol tablets if the recommended dose fails to ease their pain.

Drugmakers want Modi govt to defer revision of essential medicines list, cite Covid crisis

Drugmakers have also requested the government to consider ‘essentiality’ of the drug, and not its ‘turnover’, as the criterion for inclusion under NLEM.

Kodak is becoming a pharma company, and investors are loving it

The photo company is attempting to enter a low-margin commodity market with no particular advantage outside of the Trump administration's industrial policy.

On Camera

We can’t just blame Muslims and Englishmen for shattered Hindu unity: RSS chief Deoras

In May 1974, RSS chief Madhukar Dattatraya Deoras spoke at a lecture series in Pune about caste-based discrimination and social equality within the Hindu fold.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

With MiG-21’s exit, India’s squadron strength hits 6-decade low. What are IAF’s plans for the Tejas

While the IAF remains committed to the Tejas programme and has placed orders for 180 Tejas Mk1A, the force is eagerly waiting for the Tejas Mk 2 version.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.